05:45 AM EST, 12/13/2024 (MT Newswires) -- Nyxoah ( NYXH ) said Friday it commercially launched its Genio therapy for obstructive sleep apnea in England.

The company said it completed its first two Genio implants at University College London Hospitals.

Genio is now covered under the specialized services devices program of England's National Health Service, Nyxoah ( NYXH ) said.

The Genio system is Nyxoah's ( NYXH ) proprietary device implanted under the chin to help with sleep apnea symptoms.

Shares of the company were up more than 8% in recent Friday premarket activity.

Price: 8.57, Change: +0.69, Percent Change: +8.76